The influence of physicians' guideline compliance on patients' statin adherence: A retrospective cohort study

American Journal Geriatric Pharmacotherapy

Volumn 3, Issue 4, 2005, Pages 229-239

  Campione, Joanne R ^a,b,c   Sleath, Betsy ^b   Biddle, Andrea K ^a   Weinberger, Morris ^a,c  

^a The University of North Carolina at Chapel Hill   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c DURHAM VA MEDICAL CENTER   (United States)

Author keywords

Patients' adherence; Physician guidelines; Racial disparities; Statin therapy

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DOCTOR PATIENT RELATION; FEMALE; FOLLOW UP; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MEDICAL PROFESSION; PATIENT COMPLIANCE; POPULATION DISTRIBUTION; PRACTICE GUIDELINE; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RACE DIFFERENCE; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; UNITED STATES;

EID: 33144471357     PISSN: 15435946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjopharm.2005.12.001     Document Type: Article

References (52)

1. Nissen S.E. Tuzcu E.M. Schoenhagen P. et al. Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) Investigators. Statin therapy, LDL cholesterol, C-reactive protein, andcoronary artery disease N Engl J Med 352 2005 29-38
2. Heart Protection Study Collaborative Group MRC/ BHF Heart Protection Study of cholesterol loweringwith simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial Lancet 360 2002 7-22
3. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S) Lancet 344 1994 1383-1389
4. Cheung B.M. Lauder I.J. Lau C.P. Kumana C.R. Metaanalysis of large randomized controlled trials to evaluate the impact of statins on cardiovascular outcomes Br J Clin Pharmacol 57 2004 640-651
5. Maviglia S.M. Teich J.M. Fiskio J. Bates D.W. Using an electronic medical record to identify opportunities to improve compliance with cholesterol guidelines J Gen Intern Med 16 2001 531-537
6. Abookire S.A. Karson A.S. Fiskio J. Bates D.W. Use and monitoring of "statin" lipid-lowering drugs compared with guidelines Arch Intern Med 161 2001 53-58
7. Benner J.S. Glynn R.J. Mogun H. et al. Long-term persistence in use of statin therapy in elderly patients JAMA 288 2002 455-461
8. Avorn J. Monette J. Lacour A. et al. Persistence of use of lipid-lowering medications: A cross-national study JAMA 279 1998 1458-1462
9. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2001 2486-2497
10. Pearson T.A. Laurora I. Chu H. Kafonek S. The Lipid Treatment Assessment Project (L-TAP): A multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals Arch Intern Med 160 2000 459-467
11. McBride P. Schrott H.G. Plane M.B. et al. Primary care practice adherence to National Cholesterol Education Program guidelines for patients with coronary heart disease Arch Intern Med 158 1998 1238-1244
12. Jackevicius C.A. Mamdani M. Tu J.V. Adherence with statin therapy in elderly patients with and without acute coronary syndromes JAMA 288 2002 462-467
13. Ellis J.J. Erickson S.R. Stevenson J.G. et al. Suboptimal statin adherence and discontinuation in primary and secondary prevention populations J Gen Intern Med 19 2004 638-645
14. Schectman G. Hiatt J. Drug therapy for hypercholesterolemia in patients with cardiovascular disease: Factors limiting achievement of lipid goals Am J Med 100 1996 197-204.
15. Frolkis J.P. Pearce G.L. Sprecher D.L. Impact of nonprescriptive factors on low-density lipoprotein cholesterol reduction with statins Am J Cardiol 94 2004 1310-1312
16. Sokol M.C. McGuigan K.A. Verbrugge R.R. Epstein R.S. Impact of medication adherence on hospitalization risk and healthcare cost Med Care 43 2005 521-530
17. Frolkis J.P. Pearce G.L. Nambi V. et al. Statins do not meet expectations for lowering low-density lipoprotein cholesterol levels when used in clinical practice Am J Med 113 2002 625-629
18. Andrade S.E. Saperia G.M. Berger M.L. Platt R. Effectiveness of antihyperlipidemic drug management in clinical practice Clin Ther 21 1999 1973-1987
19. Wei L. Wang J. Thompson P. et al. Adherence to statin treatment and readmission of patients after myocardial infarction: A six year follow up study Heart 88 2002 229-233
20. Osterberg L. Blaschke T. Adherence to medication N Engl J Med 353 2005 487-497
21. Doescher M.P. Saver B.G. Franks P. Fiscella K. Racial and ethnic disparities in perceptions of physician style and trust Arch Fam Med 9 2000 1156-1163
22. Oddone E.Z. Petersen L.A. Weinberger M. et al. Contribution of the Veterans Health Administration in understanding racial disparities in access and utilization of health care: A spirit of inquiry Med Cave 40 Suppl 1 2002 I3-I13
23. Saha S. Arbelaez J.J. Cooper L.A. Patient-physician relationships and racial disparities in the quality of health care Am J Public Health 93 2003 1713-1719
24. [published correction appears in Med Care. 2003;41:1330] Tucker C.M. Herman K.C. Pedersen T.R. et. al. Cultural sensitivity in physician-patient relationships: Perspectives of an ethnically diverse sample of low-income primary care patients Med Care 41 2003 859-870
25. Ashton C.M. Peterson N.J. Wray N.P. Yu H.J. The Veterans Affairs medical care system: Hospital and clinic utilization statistics for 1994 Med Care 36 1998 793-803
26. Hanlon J.T. Weinberger M. Samsa G.P. et. al. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy Am J Med 100 1996 428-437
27. Agha Z. Lofgren R.P. VanRuiswyk T.V. Layde P.M. Are patients at Veterans Affairs Medical Centers sicker? A comparative analysis of health status and medical resource use Arch Intern Med 160 2000 3252-3257
28. Morgan R.O. Teal C.R. Siddharta G.B. et al. Measurement in Veterans Affairs health services research: Veterans as a special population Health Serv Res 40 2005 1573-1583
29. Maynard C. Chapko M.K. Data resources in the Department of Veterans Affairs Diabetes Cave 27 Suppl 2 2004 B22-B26
30. Available at:[Eh] [ir]wwwvirec.research. med.va.gov/DataSourcesName/ DataNames.htm. VA Information Resource Center US Dept of Veterans Affairs Accessed December 7 Data sources 2004
31. Pasternak R.C. Smith S.C. Jr Bairey-Merz C.N. et al. American College of Cardiology, the American Heart Association, and the National Heart, Lung, and BloodInstitute ACC/AHA/NHLBI clinical advisory on the use and safety of statins J Am Coll Cardiol 40 2002 567-572
32. Stagnitti M.N. Top 10 Outpatient Prescription Medicines Ranked by Utilization and Expenditures for the Elderly in the U.S. Community Population, 2002. Statistical Brief #66 2005 Agency for Healthcare Research and Quality Rockville, Md
33. Stagnitti M.N. Top 10 Outpatient Prescription Medicines Ranked by Utilization and Expenditures for the Near Elderly in the U.S. Community Population, 2002. Statistical Brief #65 2005 Agency for Healthcare Research and Quality Rockville, Md
34. Steiner J.F. Prochazka A.V. The assessment of refill compliance using pharmacy records: Methods, validity, and applications J Clin Epidemiol 50 1997 105-116
35. December Management of Dyslipidemia Working Group VHA/DoD Clinical Practice Guideline for the Management of Dyslipidemia in Primary Cave. Version 1.2 2001 Veterans Health Administration/Department of Defense
36. McKenney J.M. Jones P.H. Adamczyk M.A. et al. STELLAR Study Group Comparison of the efficacy of rosuvastatin versus atorvastatin, simvastatin, and pravastatin in achieving lipid goals: Results from the STELLAR trial Curr Med Res Opin 19 2003 689-698
37. [pubfished correction appears in Biometrics. 1989;45:347] Zeger S.L. Liang K.Y. Albert P.S. Models for longitudinal data: A generalized estimating equation approach Biometrics 44 1988 1049-1060
38. (Suppl) Davidson M.H. Strategies to improve Adult Treatment Panel III guideline adherence and patient compliance Am J Cardiol 89 2002 8C-22C
39. Benner J.S. Tierce J.C. Ballantyne C.M. et al. Follow-up lipid tests and physician visits are associated with improved adherence to statin therapy PharmacoEconomics 22 Suppl 3 2004 13-23
40. Yang C.C. Jick S.S. Testa M.A. Discontinuation and switching of therapy after initiation of lipid-lowering drugs: The effects of comorbidities and patient characteristics Br J Clin Pharmacol 56 2003 84-91
41. Kiortsis D.N. Giral P. Bruckert E. Turpin G. Factors associated with low compliance with lipid-lowering drugs inhyperlipidemic patients J Clin Pharm Ther 25 2000 445-451
42. Balkrishnan R. The importance of medication adherence in improving chronic-disease related outcomes. What we know and what we need to further know Med Care 43 2005 517-519
43. LaRosa J.H. LaRosa J.C. Enhancing drug compliance in lipid lowering treatment Arch Fawn Med 9 2000 1169-1175
44. Clark L.T. Treating dyslipidemia with statins: The risk-benefit profile Am Heart J 145 2003 387-396
45. Olson K.L. Bungard T.J. Tsuyuki R.T. Cholesterol risk management: A systematic examination of the gap from evidence to practice Pharmacotherapy 21 2001 807-817
46. Bultman D.C. Svarstad B.L. Effects of physician communication style on client medication beliefs and adherence with antidepressant treatment Patient Educ Couns 40 2000 173-185
47. McGlynn E.A. Asch S.M. Adams J. et al. The quality of health care delivered to adults in the United States N Engl J Med 348 2003 2635-2645, 2648
48. Ma J. Stafford R.S. Cockburn I.M. Finkelstein S.N. A statistical analysis of the magnitude and composition of drug promotion in the United States in 1998 Clin Ther 25 2003 1503-1517
49. Shepherd J. Resource management in prevention of coronary heart disease: Optimising prescription of lipid-lowering drugs Lancet 359 2002 2271-2273
50. [published correction appears in Circulation. 2004;110:763] Grundy S.M. Cleeman J.I. Merz C.N. et al. National Heart, Lung, and Blood Institute, the American College of Cardiology Foundation, and the American Heart Association Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines Circulation 110 2004 227-239
51. Eaton C.B. Stamp M.J. National Cholesterol Education Program (NCEP) The Adult Treatment Panel III Guidelines. Practice patterns related to the Adult Treatment Panel III guidelines in primary care Am J Cardiol 90 2002 687
52. Stilley C.S. Sereika S. Muldoon M.F. et al. Psychological and cognitive function: Predictors of adherence with cholesterol lowering treatment Ann Behav Med 27 2004 117-124